111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) shares were up 0.6% during trading on Wednesday. The stock traded as high as $3.22 and last traded at $3.15. Approximately 6,438 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 11,531 shares. The stock had previously closed at $3.13.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, October 13th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, 111 presently has a consensus rating of “Sell”.
Read Our Latest Stock Report on YI
111 Price Performance
The stock has a market cap of $25.25 million, a PE ratio of -1.80 and a beta of 0.67. The business has a 50 day moving average price of $3.40 and a two-hundred day moving average price of $4.42.
111 (NASDAQ:YI – Get Free Report) last announced its quarterly earnings results on Friday, September 18th. The company reported ($0.60) earnings per share for the quarter. The business had revenue of $338.55 million for the quarter.
111 Company Profile
111, Inc (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.
Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods.
Further Reading
- Five stocks we like better than 111
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
